FDA Approves New Non-Hormonal Treatment for Hot Flashes

The US Food and Drug Administration approved a non-hormonal therapy called Veozah to treat hot flashes associated with menopause.
Veozah works by blocking a chemical in the brain that regulates nerve cell activity.
Veozah can be used to relieve moderate to severe menopause symptoms like hot flashes and night sweats.
As a non-hormonal treatment, Veozah provides an alternative to hormone replacement therapy for menopausal women.
The approval of Veozah gives women experiencing menopause a new option for relief from their symptoms.